HeartFlow Stock
Cardiovascular application software
About HeartFlow Stock
HeartFlow is a medical technology company that provides non-invasive coronary artery disease detection services. The company's main product is HeartFlow FFRCT Analysis, which aims to help a physician evaluate whether a patient has significant coronary artery disease. HeartFlow FFRCT Analysis uses a CT scan that is ordered by a physician to generated a 3D model of the patient's coronary arteries. The analysis aims to calculate the amount of blockage in the arteries and the limited blood flow.
The company additionally offers HeartFlow Planner which allows physicians to model treatment strategies for coronary artery disease.
The company is currently operating with business as usual, albeit with smaller, isolated teams. HeartFlow is allowing for hospitals to divert resources toward COVID-19 by letting algorithms replace invasive procedures like angiograms.
Christopher K. Zarins and Charles Anthony Taylor founded Cardiovascular Simulation in 2007 that became HeartFlow in May 2009. The company is headquartered in Redwood City, California.
Investors
Baillie Gifford
Spotify, AUTO1 Group, Ginkgo Bioworks, Carbon, Joby Aviation, Indigo AG, HeartFlow, Tempus, Thumbtack, HelloFresh
LifeForce Capital
Martis Capital
Wellington Management
Funding History
| July 2009 | $2.0M |
|---|---|
| August 2010 | $6.9M |
| August 2010 | $10.1M |
| December 2011 | $105M |
| January 2015 | $111M |
| November 2017 | $340M |
Management
Chief Executive Officer & President
Dana Mead
Executive Vice President and Chief Medical Officer
Campbell Rogers
Chief Technology Officer and Founder
Charles Taylor
Chief Commercial Officer
Lance Scott
Chief Ethics & Compliance Officer & General Counsel
Noemi Espinosa
Vice President and Chief People Officer
Renata Naoumov
Founder, Senior Vice President of Medical Affairs
Christopher K. Zarins
Senior Vice President, Market Access and Reimbursement
Heather A. Brown
Senior Vice President, Clinical, Quality and Regulatory
Windi Hary
Vice President, Chief Information Security Officer
Auston Davis
Press
BioWorld - Jan, 31 2020
businesswire - Sep, 12 2019
bioportfolio - May, 23 2019
computerworlduk - Feb, 21 2019
massdevice - Feb, 8 2019
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from HeartFlow or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
